These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 36229881)

  • 1. Matrix stiffness-dependent STEAP3 coordinated with PD-L2 identify tumor responding to sorafenib treatment in hepatocellular carcinoma.
    Wang S; Chen L; Liu W
    Cancer Cell Int; 2022 Oct; 22(1):318. PubMed ID: 36229881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix stiffness-dependent PD-L2 deficiency improves SMYD3/xCT-mediated ferroptosis and the efficacy of anti-PD-1 in HCC.
    Wang S; Yuan X; Yang Z; Zhang X; Xu Z; Yang L; Yang X; Zhou W; Liu W
    J Adv Res; 2024 Aug; ():. PubMed ID: 39159723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulated Ferroptosis-Related Gene STEAP3 as a Novel Diagnostic and Prognostic Target for Hepatocellular Carcinoma and Its Roles in Immune Regulation.
    Yan Y; Liang Q; Xu Z; Huang J; Chen X; Cai Y; Peng B; Yi Q
    Front Cell Dev Biol; 2021; 9():743046. PubMed ID: 34790664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of genomic selection and experimental techniques to predict cell death and immunotherapeutic efficacy of ferroptosis-related CXCL2 in hepatocellular carcinoma.
    Yi Q; Liang Q; Liu Y; Gong Z; Yan Y
    Front Oncol; 2022; 12():998736. PubMed ID: 36276119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-tumor immunity and ferroptosis of hepatocellular carcinoma are enhanced by combined therapy of sorafenib and delivering modified GO-based PD-L1 siRNAs.
    Li Z; Bu J; Zhu X; Zhou H; Ren K; Chu PK; Li L; Hu X; Ding X
    Biomater Adv; 2022 May; 136():212761. PubMed ID: 35929305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of the ferroptosis-related
    Yuan L; Liu J; Bao L; Qu H; Xiang J; Sun P
    Front Oncol; 2023; 13():1032364. PubMed ID: 37064114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma.
    Xu Z; Peng B; Liang Q; Chen X; Cai Y; Zeng S; Gao K; Wang X; Yi Q; Gong Z; Yan Y
    Front Immunol; 2021; 12():719175. PubMed ID: 34603293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferroptosis-related STEAP3 acts as predictor and regulator in diffuse large B cell lymphoma through immune infiltration.
    Chen X; Hu S; Han Y; Cai Y; Lu T; Hu X; Chu Y; Zhou X; Wang X
    Clin Exp Med; 2023 Oct; 23(6):2601-2617. PubMed ID: 36682001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated Analysis Reveals Critical Ferroptosis Regulators and FTL Contribute to Cancer Progression in Hepatocellular Carcinoma.
    Ke S; Wang C; Su Z; Lin S; Wu G
    Front Genet; 2022; 13():897683. PubMed ID: 35651950
    [No Abstract]   [Full Text] [Related]  

  • 10. CISD2 Promotes Resistance to Sorafenib-Induced Ferroptosis by Regulating Autophagy in Hepatocellular Carcinoma.
    Li B; Wei S; Yang L; Peng X; Ma Y; Wu B; Fan Q; Yang S; Li X; Jin H; Tang S; Huang M; Li H; Liu J
    Front Oncol; 2021; 11():657723. PubMed ID: 34485112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macropinocytosis is an alternative pathway of cysteine acquisition and mitigates sorafenib-induced ferroptosis in hepatocellular carcinoma.
    Byun JK; Lee S; Kang GW; Lee YR; Park SY; Song IS; Yun JW; Lee J; Choi YK; Park KG
    J Exp Clin Cancer Res; 2022 Mar; 41(1):98. PubMed ID: 35287706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ferroptosis-Related Hub Genes in Hepatocellular Carcinoma: Prognostic Signature, Immune-Related, and Drug Resistance Analysis.
    Wang W; Pan F; Lin X; Yuan J; Tao C; Wang R
    Front Genet; 2022; 13():907331. PubMed ID: 35938001
    [No Abstract]   [Full Text] [Related]  

  • 13. Ferroptosis Suppressor Protein 1 Inhibition Promotes Tumor Ferroptosis and Anti-tumor Immune Responses in Liver Cancer.
    Cheu JW; Lee D; Li Q; Goh CC; Bao MH; Yuen VW; Zhang MS; Yang C; Chan CY; Tse AP; Sit GF; Liu CX; Ng IO; Wong CM; Wong CC
    Cell Mol Gastroenterol Hepatol; 2023; 16(1):133-159. PubMed ID: 36893885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of GABARAPL1 confers ferroptosis resistance to cancer stem-like cells in hepatocellular carcinoma.
    Du X; Qi Z; Xu J; Guo M; Zhang X; Yu Z; Cao X; Xia J
    Mol Oncol; 2022 Oct; 16(20):3703-3719. PubMed ID: 36062307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SPARC regulates ferroptosis induced by sorafenib in human hepatocellular carcinoma.
    Hua HW; Jiang HS; Jia L; Jia YP; Yao YL; Chen YW; Jiang F; Lu DQ; Zhou Q; Jiang MW; Ding G
    Cancer Biomark; 2021; 32(4):425-433. PubMed ID: 33843664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Ferroptosis-Elicited Inflammation Suppresses Hepatocellular Carcinoma Metastasis and Enhances Sorafenib Efficacy.
    Mu M; Huang CX; Qu C; Li PL; Wu XN; Yao W; Shen C; Huang R; Wan CC; Jian ZW; Zheng L; Wu RQ; Lao XM; Kuang DM
    Cancer Res; 2024 Mar; 84(6):841-854. PubMed ID: 38231484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive characterization of ferroptosis in hepatocellular carcinoma revealing the association with prognosis and tumor immune microenvironment.
    Zhu J; Xu X; Jiang M; Yang F; Mei Y; Zhang X
    Front Oncol; 2023; 13():1145380. PubMed ID: 37051544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STEAP3 Affects Ovarian Cancer Progression by Regulating Ferroptosis through the p53/SLC7A11 Pathway.
    Han Y; Fu L; Kong Y; Jiang C; Huang L; Zhang H
    Mediators Inflamm; 2024; 2024():4048527. PubMed ID: 38440354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ferroptosis-related long non-coding RNA signature predicts the prognosis of hepatocellular carcinoma.
    Yang X; Mei M; Yang J; Guo J; Du F; Liu S
    Aging (Albany NY); 2022 May; 14(9):4069-4084. PubMed ID: 35550563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing.
    Hao X; Zheng Z; Liu H; Zhang Y; Kang J; Kong X; Rong D; Sun G; Sun G; Liu L; Yu H; Tang W; Wang X
    Redox Biol; 2022 Oct; 56():102463. PubMed ID: 36108528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.